Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition with significant genetic influences.
• Evidence from twin and family studies strongly supports a genetic etiology for ASD.
• Associated medical conditions and cellular abnormalities in the limbic system and cerebellum are observed in some individuals with ASD.

Purpose of the Study:

• To explore the genetic underpinnings of autism.
• To investigate neurobiological markers associated with autism.
• To evaluate potential pharmacological treatments for autism.

Main Methods:

• Utilizing an affected sib pair strategy in an international consortium to identify genetic linkages.
• Analyzing postmortem brain tissue and magnetic resonance imaging (MRI) data.
• Examining whole blood serotonin (5-hydroxytryptamine; 5-HT) levels in patients.

Main Results:

• A promising genetic linkage to a region on chromosome 7 has been identified.
• Macrocephalia and increased total brain tissue volume, particularly in occipital and parietal lobes, are noted in 10-20% of individuals with autism.
• Elevated whole blood serotonin (5-HT) levels are a consistent finding in over 30% of patients.

Conclusions:

• Genetic factors play a substantial role in the etiology of autism.
• Neurobiological abnormalities, including altered brain volume and elevated serotonin, are associated with autism.
• Pharmacological interventions targeting serotonin and dopamine receptors show potential clinical benefit and warrant further investigation.